SECOND SYMPOSIUM ON CONTINUOUS FLOW TECHNOLOGY IN INDUSTRY
17-19 March 2014, Robinson College, Cambridge, UK
This international conference, organized by the Royal Society of Chemistry Speciality Chemicals Sector, and sponsored by Continuous Manufacturing and Crystallisation (CMAC) and Chemistry Innovation Knowledge Transfer Network (CIKTN), was held in the historic city of Cambridge, UK, at Robinson College, following on from the Continuous Flow Technology symposia at Chemspec Geneva 2011 and Munich 2013, and the first Continuous Flow Technology in Industry conference in York 2012.More than one hundred people attended this high level technical event. Speakers, exhibitors and posters presenters had the opportunity to discuss about continuous processes during coffee breaks and lunches. An optional workshop session on “Redefining the 21st Century end-to-end Pharma Supply Chain through enhanced Manufacturing Flexibility”, was organized on the day of the build-up, and led by Jag Srai, Cambridge Institute for Manufacturing, UK, and Simon Rushworth, Chemistry Innovation Knowledge Transfer Network, UK. Paper forms were distributed and filled in to understand the background of participants and give recommendations to funding bodies of where future investment would benefit industry. A welcome cocktail followed in the exhibition area.The two-day conference opened with the keynote lecture of Steven Ley, University of Cambridge, UK, included in the list of “100 most important people in British science” by The Times in 2011. His speech concentrated on the need to make molecules more efficiently and more sustainable with the use of continuous flow processing, without the use of conventional work-up procedures. The speakers who came after highlighted recent developments in the fine, speciality chemicals and pharma industries.
- Continuous flow reactors and equipment on an production scale
- Continuous crystallization
- Comparison of batch and continuous processes
- Scale up of exothermic and hazardous chemistry
- Continuous flow technology for the pharmaceutical industry
- Real time monitoring in continuous flow
On the evening of the first day a cocktail reception and dinner open to all the participants was arranged at the Old Courts Dining Room at Gonville and Caius College, the fourth-oldest college at the University of Cambridge and one of the wealthiest. Participants spent a nice evening talking about chemistry but also about politics and personal life, getting to know each other more.
The symposium closed with the promise of meeting once again in perhaps 2 years’ time and exchange positive and negative results and most of all challenges.
THE SECOND BELGIAN PEPTIDE GROUP MEETING
The second Belgian Peptide Group Meeting (BPGM) was held in Ghent on February 10-11, 2014. The venue took place in the nice Het Pand monastery with over 160 attendees from academia and industry. For this second edition, the Organizers provided the opportunity for industry partners to exhibit. Nine companies exhibited at the conference and few others increased their visibility through sponsorship. Once again the Organizing Committee and the Scientific Committee have put together an exciting scientific program consisting of 4 plenary lectures and 20 oral communications as well as 43 posters.
About 50% of the attendees were from Belgium. Others were from several other countries. The is an international conference intended to cover several topics in the peptide therapeutic field from research and discovery, development, identification and characterization as well as peptide manufacture.This meeting has further contributed to further stimulating the interactions between scientists in the field and help identify new opportunities for the future.It is the aim and intention of the Organizers to have participants from academia and industry and help bridging the gap and get the peptide community under one single “roof”.
This diversified conference is organized by
Prof. Steven Ballet (VUBrussels),
Dr. Mimoun Ayoub (Corden Pharma),
Prof. Annemieke Madder (UGhent),
Prof. Dirk Tourwé (VUBrussels)
and Prof. Jose Martins (UGhent)
under the auspices of the European
Peptide Society and with the support
of The Research Foundation - Flanders (FWO).